22-23 PHARMA - Fast and the curious This month: the NHS as a dystopian game of Tetris, the GLP-1 explosion and its impact on future meds, plus deep dives into AI in pharma, reproductive health, and Trump’s healthcare influence. Also, co...

#mRNAvaccines #GLP1 #obesity #CARTcelltherapies #oncology #PCSK9inhibitors #HepatitisC #Immunotherapy #checkpointinhibitors #RSVvaccines #Genetherapies #rarediseases #antivirals #Biosimilars #expandedaccess #biologics #HIV #Migraine #CGRPinhibitors #antifungals #precisionmedicine
zurl.co/3UDz7

Immunologist Perception on Alopecia Areata Treatments (US & EU, 2026) Explore immunologist insights on alopecia areata treatments in the US and EU (2026), including JAK inhibitors, biologics, adoption trends, and key market drivers.

Immunologists are shifting toward JAK inhibitors for alopecia areata 🚀

Discover key insights on treatment trends, adoption drivers, and future therapies across the US & EU.

👉 Read the full case study:
www.sperresearch.com/Case-Studies...

#AlopeciaAreata #HealthcareTrends #Biologics #Dermatology

3-in-1 living pharmacy implant delivers HIV, GLP-1, diabetes drugs By generating oxygen inside the implant, scientists significantly improved cell survival and sustained multi-drug delivery over 30 days.

3-in-1 #living #pharmacy #implant #delivers #continuous #HIV, #GLP1, and #diabetes #drugs. #Medicine #surgery #tablets #injections #startrek #device #tech #science #health #cyborg #HOBIT #biologics interestingengineering.com/health/impla...

Samsung Biologics Completes GSK MD Facility Deal Samsung Biologics closed the acquisition of GSK's Maryland biologics facility on Mar 31, 2026, expanding its U.S. footprint and changing CDMO competitive dynamics.

Samsung Biologics Completes GSK MD Facility Deal: Samsung Biologics closed the acquisition of GSK's Maryland biologics facility on Mar 31, 2026, expanding its U.S. footprint and changing CDMO competitive dynamics. 👈 Read full analysis #SamsungBiologics #GSK #Biologics #CDMO #Pharmaceuticals

Promotional graphic from the Canadian Arthritis Patient Alliance (CAPA) for a webinar titled “Getting on a Biologic Medication” as part of the Lived Experience Series. The webinar takes place March 31, 2026 at 6:00 PM EDT and lasts 1 hour. Speakers include Megan Friedman (Educator and Disability Advocate), Dr. Quinn Grundy (Registered Nurse), and Dr. Alexandra Legge (Rheumatologist), shown with headshots. A QR code is included for registration.

⏳ Just 1 day to go!
Last chance to register for our free webinar “Getting on a Biologic Medication.”

👉 Save your spot: buff.ly/VY9Dl7R

#Biologics #PatientSupportPrograms #InflammatoryArthritis #RareDisease

#KNCVMCCB2026 comes to an end with an interesting talk by Danielle Vugts. She talked about the importance of #imaging during #DrugDevelopment on the example of PET imaging of #biologics.

link.springer.com/article/10.1...
#DrugDiscovery #PETImaging #Radiolabeling #Antibodies #Nanoparticles #ChemSky

LC/MS is transforming HCP analysis in biopharma.
Hear Alphalyse, host cell protein CRO, share insights on applying LC/MS for deeper characterization, covering regulatory aspects, strategy, and performance. #lcms #proteomics #biologics #biopharma #drugdevelopment

#biologics #analytical | Teddy Zartler Discussion topic for my #Biologics #Analytical folks. When validating a method, such as SEC, is it sufficient to establish the range and linearity via the response of the detector? Or, should you ge...

For my #Biologics #Analytical folks. Discussion topic for my hashtag#Biologics hashtag#Analytical folks. Hop on this discussion www.linkedin.com/posts/teddyz...
TL;DR validate the response of the detector or the CQA species?

Validated for potency testing and lot release: Assay Ready Thaw-and-Use Cells for mAbs (FcγR/ADCC/ADCP), checkpoint inhibitors (PD-1/PD-L1, 4-1BB), cytokine receptors (IL-1, VEGF).

Batches to 1,000 vials, stringent QC.

More at: https://ow.ly/NLYW50YlT37

#Bioassay #Biologics

[ALA Client News] Bio‑Sourcing and Tiny Cargo join forces to develop oral delivery therapies of monoclonal antibodies using goat‑milk exosomes

ala.associates/partnership/...

#exosomes #biologics

Thanks for having us, #FestivalofBiologics! #biologics

The Rapid Growth of the Prefilled Syringes Market: Projections Indicate Over $18 Billion by 2031 The prefilled syringes market is on a robust growth trajectory, expected to exceed $18 billion by 2031, driven by biologics and self-injection trends.

The Rapid Growth of the Prefilled Syringes Market: Projections Indicate Over $18 Billion by 2031 #India #Hyderabad #Biologics #Prefilled_Syringes #self-injection

Final results from the vedolizumab extended access program multinational study demonstrate long-term treatment persistence and safety
@tagastroenterol.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#biologics #IBD #Chrohns #colitis #gastroenterology #medicine #openaccess

#ICYMI: Always Look on the Bright Side of (Cell) Death, cytotoxicity assays for antibody drug conjugate development.

Darren Heywood (Promega), Grant Harradence & Robert Francis (Abzena) on ADC potency testing.

Go to https://ow.ly/9TNQ50Ymycj to watch for free

#AntibodyDrugConjugates #Biologics

IDBS Receives Biologics Digitalisation Software Innovation Award at ABEA 2026 WOKING, United Kingdom — IDBS, a cloud software provider serving the biopharmaceutical industry and part of the Danaher group, has been recognised with the Best Biologics Digitalisation: Software Innovation Award at the Asia Pacific Biopharma Excellence Awards (ABEA) 2026. The award highlights the company’s role in advancing digital transformation and strengthening innovation within the biopharmaceutical …

IDBS Receives Biologics Digitalisation Software Innovation Award at ABEA 2026 #Biopharmaceutical #DigitalTransformation #InnovationAward #Biologics #CloudSoftware

Thrilled to share our latest publication 🎉 5-year data in CRSwNP confirms dupilumab delivers durable disease control with excellent safety. Personalised dosing-interval extension kept efficacy high while cutting treatment burden.
#Immunology #CRS #Biologics
🔗 onlinelibrary.wiley.com/doi/10.1002/...

Journal club webinar on the "effect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging in patients with type 2 asthma (VESTIGE)." starts in one hour. looking forward to seeing you there!
#asthma
#biologics

Abselion has established a US Subsidiary at The Engine
at MIT in Cambridge MA

🗞️Read the #pressrelease abselion.com/abselion-est...

🤝 Meet the team #BPIWest & #ELRIGCGT26

#Amperia #NorthAmerican #lifesciences
#academic #biotech #biologics #pharma #research
#messengersinscience

Reminder: Free webinar TOMORROW (Wed 11 Mar 2026, 2pm GMT) - From Concept to Validation: Faster Development with Qualified Cell-Based Assay Kits.

Join BioAgilytix & Promega on kit vs in-house, GMP compliance, biologics applications.

https://ow.ly/zsom50Yiivx

#Biologics #CellBasedAssays

Lights-Out, e2e, Process Intensification (PI) / Continuous Mfg:
Reshaping the Economics of Your Tox, Clinical & Commercial Biologics Supply

We're writing an e-book. Publish date: Q2/2026

Get on the Waiting List for your free copy.

biotech-1.com#s-b95c7600-d...

#gmp #biotechnology #biologics

#Biopharmaceutical manufacturing starts with science.

Build #biotech capability where it matters.

Explore our Biotechnology for Biopharmaceutical Manufacturing suite at: www.skillpad.com

#BiotechManufacturing #GMPTraining #Biologics #CellAndGeneTherapy #elearning #training

Cell assay development challenge: in-house is slow & variable. Commercial kits deliver speed, consistency, GMP compliance

Join Promega and BioAgilytix for a free webinar 11 Mar, 2pm GMT looking at a real-world case study on ADCC and T Cell Activation kits: https://ow.ly/UQyE50YigcX

#Biologics

Selected Biologics Symposium recordings (from Nov 2025) are now available online for free.

Topics include: antibody therapeutics, cell and gene therapy, analytical methods, manufacturing, QC for advanced therapeutics.

Watch at: https://ow.ly/khA950YkT0W

#Biologics #CellTherapy

Avid Bioservices Unveils New Early Phase Center in Costa Mesa, California Avid Bioservices has announced the launch of a state-of-the-art Early Phase Center of Excellence in Costa Mesa, California, to enhance their service offerings.

Avid Bioservices Unveils New Early Phase Center in Costa Mesa, California #USA #Avid_Bioservices #Costa_Mesa #Biologics #Early_Phase_Center

Avid Bioservices Unveils New Early Phase Center of Excellence in Costa Mesa, California Avid Bioservices has inaugurated a new Early Phase Center of Excellence in Costa Mesa, California, enhancing its biologics development capabilities significantly.

Avid Bioservices Unveils New Early Phase Center of Excellence in Costa Mesa, California #USA #Avid_Bioservices #Costa_Mesa #CDMO #Biologics

Biologics-induced cutaneous pseudolymphomas: a narrative review with an illustrative case of brodalumab-induced pseudolymphoma - Drugs in Context The authors provide a concise narrative review of biologic-induced cutaneous pseudolymphomas and illustrate the topic with the first reported case of brodalumab-induced pseudolymphoma in a patient wit...

💊 Biologics-induced cutaneous pseudolymphomas: a narrative review with an illustrative case of brodalumab-induced pseudolymphoma

Almeida Silva et al.

www.drugsincontext.com/biologics-in...

#dermatology #biologics #immunology #pseudolymphoma @medsky.social @pharmsky.pharmsky.app @me.pharmsky.app

🔬 Research Spotlight: Biologics in Foot & Ankle Surgery

Review examines evidence for PRP, BMAC, and other biologics in foot surgery. Key takeaway: promising but needs more high-quality trials.

#Orthopedics #FootAndAnkle #Biologics

US Intravenous Immunoglobulin Market Size, Industry Growth - 2035 US Intravenous Immunoglobulin Market share register 2700 USD Million in 2024, projected to grow 3.75 % CAGR to reach USD Million 4050 during the forecast period 2025 - 2035.

Growing autoimmune treatments boost the US Intravenous Immunoglobulin Market. Details: www.marketresearchfuture.com/reports/us-i...
#Biologics

EAACI Task Force Report highlights Chronic rhinosinusitis (CRS) & #asthma, especially severe N-ERD, are linked by type 2 inflammation. While transformative #biologics target this, personalized treatments and more trials are needed to optimize care.
#CRS #Immunology

🔗 ino.to/fW9sKQh

Meet us at booth 213 at the Festival of Biologics in San Diego! #biologics